P25 HER2 Testing in 538 consecutive breast cancer cases using immunohistochemistry and fluorescence in situ hybridization
- 作者A. Kovács; G. Stenman
- 卷第16卷
- 印刷ISSN0960-9776
- 文件大小46.45KB
- 发表时间2007
- DOI10.1016/s0960-9776(07)70090-5
532 TRANSCRIPTOME ANALYSIS OF QUERCETIN EFFECT IN HEPATOCELLULAR CANCER CELLSG. Notas; A.-P. Nifli; M. Kampa; V. Pelekanou; J. Vercauteren; E. Castanas · 2009
Regulation of TNF-superfamily members by erythropoietin, in breast cancerV. Pelekanou; M. Kampa; K. Darivianaki; E.N. Stathopoulos; A. Tsapis; E. Castanas · 2008
Erythropoietin and steroid membrane initiated actions interact in breast cancer cells leading to enhanced cell survivalM. Kampa; V. Pelekanou; D. Vassou; E. Castanas · 2008
P40 Erythropoietin (EPO) and its receptors (EPOR) detection in human breast cancer specimens: correlation with steroid receptors (membrane intracellular) and other biological and clinical indicesV. Pelekanou; M. Kampa; M. Kafousi; K. Dambaki; K. Darivianaki; T. Vrekousis; E. Sanidas; D. Tsiftsis; E. Stathopoulos; E. Castanas · 2007